PHASE Ib CLINICAL TRIAL FOR AMD YIELDS PROMISING RESULTS.

Image via Wikipedia

MacuCLEAR, Inc. and Mystic Pharmaceuticals, Inc. have announced preliminary successful results of a Phase Ib Clinical Trial for the treatment and prevention of the progression of age-related macular degeneration (AMD). According to a press release from Mystic, the preliminary results indicated that MacuCLEAR's MC-1101 drug is safe and well tolerated by study participants, and has a biological effect on blood flow in the back of the retina. Trial participants used Mystic's VersiDoser ophthalmic delivery system to self-administer MC-1101 to the front of the eye during the trial. A key finding of the study was the successful migration of the drug to the back of the eye and the study included Proof of Concept (“POC”) indicators.

Read more »

Latisse sales through the roof!

The Los Angeles Times reports, In an otherwise lackluster beauty industry lash enhancers are all the rage.


Allergan's lash enhancer, Latisse, is the first FDA-approved lash-growing product, which is available by prescription only. Latisse grossed $25.4 million in sales in the first half of this year, and the company says it anticipates doing $60 million in total by year's end.

Meanwhile, competitors, including Dr. Simon Ourian's Epione Lash RX...came out at the end of August and sold 1,000 units in its first couple of weeks. The products are designed to be brushed close to the upper and lower lashes before bedtime, and within a few weeks lashes appear thicker and longer. But, dermatologists warn about potential sensitivity. Jessica Wu, assistant clinical professor of dermatology at USC, cautioned that people have underlying conditions, so you need to talk to your eyecare provider before starting treatment.

Read more »

FDA to study quality of life problems associated with Lasik surgery

The AP that "the Food and Drug Administration announced plans Thursday to study the scope of problems connected with laser eye-correcting surgery, which include blurred vision and dry eyes." The agency "says it will work with the National Eye Institute and the Department of Defense to determine the percentage of patients who experience negative side effects following" Lasik (laser-assisted in situ keratomileusis) surgery. Dr. Jeffrey Shuren, the acting head of FDA's medical device division, said, "This study will enhance our understanding of the risks of Lasik and could lead to a reduction in patients who experience adverse effects."

Bloomberg News that "the first phase of the study began in July and involves online questionnaires." According to Bloomberg, "pressure from patients dissatisfied with laser eye surgery prodded US regulators to begin a study of the procedure's effects and warn Lasik centers to better track complications, an advocate said." The agency said Thursday "that recent inspections showed 17 undisclosed Lasik centers had inadequate systems for reporting adverse effects of the surgery."

Although "Lasik has many ardent admirers among the more than 12 million in the US who have had it, between 2% and 5% of patients getting the surgery -- as many as 75,000 per year -- are thought to have lasting post-operative problems that range from painful dry-eye to poorer vision, halos, glare and even blindness," the Los Angeles Times "Booster Shots" blog reports. "The FDA calls these 'quality of life' problems following the laser surgery, and has acknowledged that it has recorded no more than a small fraction of such problems during the Lasik industry's period of explosive growth." CQ Today and the UK's Press Association also cover the story. Reuters, meanwhile, reports on the FDA's warning to Lasik centers.

Read more »

visuospatial skills decline three years before Alzheimer's

HealthDay reported that, according to a study published in the Oct. issue of the Archives of Neurology, the ability to perceive relationships between objects (visuospatial skills) may decline years before a person is diagnosed with Alzheimer's disease. In a study population of 444 people, researchers from the University of Kansas used data from "cognitive assessments" to chart declines in various areas before participants were diagnosed with dementia. They found an inflection point (sudden change to a steeper slope of decline) in visuospatial abilities three years before clinical diagnosis of dementia. After that, "declines in overall cognition occurred the next year, while inflection points for verbal and working memory weren't seen until one year before diagnosis."

The UK's Telegraph quotes the authors as saying that "research into early detection of cognitive disorders using only episodic memory tasks, such as word lists or paragraph recall, may not be sensitive to either all of the earliest manifestations of disease or the most rapidly changing domain.

Read more »

Medscape reported that, according to a paper appearing online in Stroke, the risk for stroke, both ischemic and hemorrhagic, is increased by 30 percent within a year of "a herpes zoster attack," a figure that soars about four-fold should the attack involve the eye (herpes zoster ophthalmicus).

Researchers in Taipei reached those conclusions after scouring the Taiwan National Health Research Institute database to estimate the incidence of stroke among 7,760 adult patients treated for herpes zoster between 1997 and 2001, according to MedPage Today . Those patients were compared with 23,280 who had not been diagnosed with shingles.

The authors explained that the major mechanism of [their] findings is that stroke results from herpes zoster virus-induced vasculopathy [blood vessel damage].

The vessel to the brain damaged by the virus could be occluded [blocked] or ruptured lead investigator Dr. Jiunn-Horng Kang said.

Read more »

AMD associated with lipoprotein build-up at back of retina

Age-related macular degeneration (ARMD) is a major cause of vision loss in the elderly and exists in two forms “wet” and “dry.”

In the “wet” form, abnormal blood vessels behind the retina grow into the macula, and can separate it from the rest of the retina leading to sight-threatening complications.

The “dry” form of the disease is much more common, but until recently was poorly understood. A leading research team in this area, led by Christine Curcio (University of Alabama School of Medicine, Birmingham, USA) summarizes current knowledge in a review published in the Journal of Lipid Research.

A build-up of lipoprotein particles at the back of the retina, similar to the build-up of cholesterol in coronary arteries, may play a key role in the development and progression of the “dry” form of age-related macular degeneration, show results from a review of recent research.

The current focus of Curcio and colleagues is Bruch’s membrane (the innermost layer of the choroid) and the retinal pigment epithelium, in particular the boundary between the retinal pigment epithelium and Bruch’s membrane.

Read more »

Angiogenesis Inhibitor Works in Macular Edema

According to two studies presented at a retina meeting, patients with macular edema related to retinal vein occlusion had significant improvement in vision when treated with ranibizumab (Lucentis) in each of two dosages. In trials including approximately 400 patients apiece, researchers from Johns Hopkins University and Houston's Methodist Hospital randomized patients to monthly 0.5 mg or 0.3 mg intravitreal injections of ranibizumab, or to sham injections, for six months. Notably, 46 to 47 percent of patients in both ranibizumab groups improved by at least 15 letters, compared with 16.9 percent of the control group.

Read more »

Save your Vision Tips!

Image via Wikipedia

Eat Dark, Leafy Greens

Spinach, kale, collard greens, and other deep-colored vegetables contain lutein and zeaxanthin, two carotenoids that “have been associated with reducing the risk of developing cataracts and macular degeneration”. Try to eat two servings a day―for example, a handful of spinach in your salad at lunch and a side of broccoli at dinner.

Antioxidants

Foods such as berries, oranges, plums, and cherries help minimize free-radical damage, which is caused by environmental factors (like sunlight and pollution) and can quicken the hardening of lenses and contribute to cataracts and macular degeneration. Eat at least two servings a day―a cup of blueberries with your breakfast, say, and an orange as an afternoon snack.

Take a Multivitamin

A National Eye Institute study showed that supplements with antioxidant vitamins C and E, beta-carotene, and the minerals copper and zinc slowed the progression of advanced macular degeneration in high-risk patients. And a recent article in the Archives of Internal Medicine concluded that vitamins B6 and B12 and folic acid may also help. Still other studies suggest that vitamins may delay the onset of cataracts.

Get Your Omega-3s

You’ve heard that they’re good for your heart, but “evidence suggests omega-3 fatty acids found in certain fish, such as salmon, halibut, and tuna, can help maintain the eyes’ protective tear film, minimize dry eyes, and even prevent cataracts. Eat two to three servings a week, or consider taking a fish-oil supplement every day. Also cut down on red meat: A recent study showed that high consumption levels may increase the risk of macular degeneration.

Get some Veggie

These crisp vegetables, as well as other orange offerings, like pumpkin and butternut squash, contain beta-carotene, a carotenoid that may help keep eyes healthy.

Swear by Sunglasses

UV light is a major player in the hardening of the lenses and the development of cataracts and macular degeneration. That means it’s important to wear sunglasses with dark lenses that filter out 100 percent of UV rays (the label should indicate this) whenever you’re outside. we also recommend patients to put on a hat. “All glasses allow some light in through the tops and the sides” . “It bounces off your cheeks and right into your eyes.” Choose one that has a brim of at least four inches.

Read more »

Vision impacts life success

MedPage Today reported that, according to a study published online in Ophthalmology, patients with age-related macular degeneration (AMD) have a 50 percent increased risk of coronary heart disease.



Researchers from the Singapore National Eye Center conducted a population-based cohort study of 1,786 patients who didn't have heart disease and 2,228 patients without stroke at baseline. Patients were between the ages of 69 and 97. The investigators found that those with early macular degeneration had a higher cumulative incidence of heart disease than those without (25.8 percent versus 18.9 percent).

Notably, there was a significantly higher cumulative incidence of heart disease for those with specific signs of early macular degeneration -- soft drusen, hyperpigmentation, and RPE depigmentation

Read more »

Handheld device detects blindness in infants

A new handheld device, developed in part by biomedical engineers at Duke University Medical Center, uses spectral domain optical coherence tomography to allow doctors to look for retinopathy of prematurity in infants, a condition that could lead to blindness.

The new device developed by Bioptigen, which creates a 3D image of the back of the eye, can even be taken to infants in the neonatal ICU, and can be used without ever touching an infant's eye. Researchers now say that it's time to determine what role the imaging could play in treatment decisions.

Duke Eye Center ophthalmologist Cynthia Toth compares the process to inspecting fish from the side of an aquarium instead of through an ocean's murky surface.

Read more »

mom forgoes treatment to save daughter from blindness

Monique Zimmerman-Stein has been nearly blind for the last two years from Stickler syndrome, a rare genetic disorder. She recently decided to forego her own treatment to save funds to treat her two daughters, who also suffer from the condition, reports Lane DeGregory of the St. Petersburg Times.

The family is covered under husband Gary's Blue Cross/Blue Shield plan, but that coverage only pays for 80 percent of medical expenses.

Read more »

In the New York Times Really? column, Anahad O'Connor explores the claim that blindness may heighten other senses. "In one series of studies, neuroscientists at McGill University tested blind and sighted subjects for pitch perception and their ability to locate sounds." The researchers found that "those who were born blind did best," while "those who became blind as small children were slightly behind, and those who lost their vision after age 10 did no better than the sighted subjects," indicating that a young brain could be rewired so that visual-processing areas were used for other purposes.

Meanwhile, brain-imaging studies indicated that blind subjects who were best able to locate sound were engaging both the auditory and the visual areas of the cortex.
Here is a nice summary of the visual system from Mcgill's guided tour of the brain

Read more »

Intravitreal injection of triamcinolone may improve vision in retinal vein occlusion

Image via Wikipedia

Medscape reported that, according to a study published in the Sept. issue of the Archives of Ophthalmology, intravitreal injection of the corticosteroid triamcinolone may improve vision in retinal vein occlusion.

Researchers from the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study Research Group compared "the efficacy and safety of one-mg and four-mg doses of preservative-free intravitreal triamcinolone vs. observation for eyes with vision loss associated with macular edema secondary to perfused" central retinal vein occlusion "in 271 participants." They found that the the one-mg group had five-fold greater odds of achieving the primary outcome, as "did the four-mg group," with both the "one-mg and four-mg groups" being "not significantly different from each other."

Read more »

Researchers advancing new ways of helping blind people see

On its front page, the New York Times reported that 38 patients from the US, Europe, and Mexico are beginning an intensive three-year research project involving electrodes surgically implanted in their eyes, a camera on the bridge of their noses, and a video processor strapped to their waists, in a burst of recent research aimed at one of science's most-sought-after holy grails: making the blind see.



Researchers involved in the project, the artificial retina, say they have plans to develop the technology to allow people to read, write and recognize faces. Meanwhile, other approaches to treating blindness include gene therapy, which has produced improved vision in people who are blind from one rare congenital disease. Stem cell research is considered promising, although far from producing results, and other studies involve a light-responding protein and retinal transplants.

Read more »

Drug-dispensing contact lens may treat eye conditions

Researchers have developed contact lenses with a sustained release of medication to treat glaucoma and other conditions.

Daniel Kohane, MD, PhD, director of the Laboratory for Biomaterials and Drug Delivery at Children's Hospital Boston, collaborator Joseph Ciolino, MD, of the Massachusetts Eye and Ear Infirmary, and colleagues at the Department of Chemical Engineering at the Massachusetts Institute of Technology (MIT) described their prototype lens in the July 2009 issue of Investigative Ophthalmology and Visual Science.

The researchers created a two-layer CL with an inner drug-bearing biodegradable polymer film known as PLGA. Both PLGA and pHEMA—used for the coating—have been well studied and are already FDA-approved for ocular use.

In laboratory testing, the prototype lenses dispensed ciprofloxacin for 30 days in amounts sufficient to kill pathogens. Researchers see application for conditions including glaucoma and dry eye, which require frequent daily eye drops. The technology won in the life sciences track in MIT's 100K Entrepreneurship Competition.

Read more »

Information System for Blind and Visually Impaired

The artificial intelligence group at Freie Universität Berlin, under the direction of the computer science professor Raúl Rojas, has developed a new type of information system for blind and visually impaired individuals.

“InformA” is a small computer that is connected wirelessly to the Internet. The device is operated like a radio. The user can choose between different information channels. By pressing a button, the time or the weather will be announced, but there are also current newspapers available as audio files...

via Google Blogoscoped

Read more »

Smoking Bans Reduce Heart Attacks

Community smoking bans have an immediate and dramatic effect on reducing heart attacks, according to two new analyses of laws in the USA, Canada, and Europe. Researchers in both studies found that heart attack rates fall 17 percent within a year after smoking bans take effect, as reported in the USA Today.



After three years, the analyses indicated that the rate of heart attacks had decreased about 26 percent, the Wall Street Journal reports. The findings are based on analyses of studies that involved a total of approximately 24 million people. The researchers cautioned against basing hard conclusions on their findings, however, because of statistical flaws in their reports from aggregating data from studies with various designs and goals.

Exactly what can breathing in the smoke from someone else's cigarette do to you? It can:

Make the blood sticky and more prone to clotting
Stiffen the arteries
Disrupt crucial functions of the arteries
Decrease good HDL cholesterol
Stimulate inflammation
Make heart attacks worse
Increase damage from free radicals
Increase risk of heart rhythm problems
Increase insulin resistance

Quit smoking without gaining weight

Read more »

Merck amp; Co., Inc. has launched SAFLUTAN® (tafluprost) in the United Kingdom and Spain, and additional launches in other countries are expected over the next several months, pending regulatory approvals, the Company said today.

SAFLUTAN is a preservative free, synthetic analogue of the prostaglandin F2α for the reduction of elevated intraocular pressure (IOP) in appropriate patients with primary open-angle glaucoma and ocular hypertension. SAFLUTAN is in Phase III in the U.S.

Merck amp; Co., Inc. which operates in many countries as Merck Sharp amp; Dohme or MSD, and Santen Pharmaceutical Co., Ltd. announced a worldwide licensing agreement for tafluprost. Under the terms of the agreement, Merck agreed to pay an undisclosed fee as well as milestones and royalty payments based on future sales of tafluprost (both preserved and preservative-free formulations) in exchange for exclusive commercial rights to tafluprost in western Europe (excluding Germany), North America, South America and Africa. Santen will retain commercial rights to tafluprost in most countries in eastern Europe, northern Europe and in countries in the Asia Pacific area, including Japan. Merck will provide promotion support to Santen in Germany and Poland. If tafluprost is approved in the U.S., Santen will have the option to co-promote it there. SAFLUTAN marketed by MSD, and TAFLOTAN®, marketed by Santen in respective territories, is the only preservative-free prostaglandin currently available for patients with glaucoma.

Read more »

ultrasound eyebrow lift

Food and Drug Administration has cleared a new ultrasound eyebrow lift device, called the Ulthera System, to be marketed to dermatologists and plastic surgeons.


Ulthera claimed that the "noninvasive device...uses ultrasound imaging to target ultrasound energy that enables significant lifting of the skin. The press release went on to say that focused ultrasound energy triggers the body's natural healing response, resulting in new and improved collagen support and gradual firming, tightening, and actual lifting of skin tissue over time, with clinical studies indicating no serious adverse events and no recuperation time.

Read more »

September is Home Eye Safety Awareness Month

Image via Wikipedia

One in five at-home eye injuries are due to home repair or power tools according to results from the “Sixth Annual Eye Injury Snapshot” by the American Society of Ocular Trauma (ASOT).

Every year, there are more than 2.5 million eye injuries; yet, the use of protective eyewear could have prevented 90% of these injuries. When starting any project, whether it is cleaning surfaces with chemicals, working on the car or doing yard work, PBA asks everyone to wear eyewear approved by the American National Standards Institute. The eyewear should have the “Z-87” logo stamped on the frames and can be purchased at hardware stores and home building centers.

PBA offers these tips on how to protect children’s eyes at home:

Teach children not to run around with forks, knives, combs, or toothbrushes.

Keep detergents, cleaning supplies, nail polish remover, mouthwash, and makeup in locked cabinets or out of reach.

Set a good example by wearing eye protection when using ammonia-based cleaning supplies or while working on projects.

Do not allow young children to use combs, brushes, or hairspray unless you watch or help them.

Prompt others who enter the work area to wear eye protection.

If you wear prescription glasses, many safety glasses or goggles will fit over your regular glasses. Ask your doctor what he or she recommends.

Read more »

The Philadelphia Inquirer reports that two months ago, surgeons at the Wills Eye Institute implanted a small array of electrodes in the back of Michael Adler's left eye. Now, in the last few weeks -- with the aid of a small video camera in his sunglasses that transmits images to his retinal implant -- he has begun to gain some limited vision.

To date, surgeons have implanted the devices in the retinas of 32 people around the world. All have a severe form of retinitis pigmentosa, an inherited disease that causes retinal degeneration. The retinal implant bypasses damaged cells in the eye, transmitting signals to the same part of the brain that registers images in people with normal vision. While the resulting black-and-white images are very low-resolution, consisting of just 60 pixels, they do allow Adler to see the outlines of doors and sidewalks, and he can pick out plates on the dinner table

Read more »

According to a study in Wednesday's Journal of the American Medical Association, the antibiotic Zithromax [azithromycin], which is widely used in Africa to treat the eyesight-robbing infection trachoma, seems to help prevent Ethiopian children from dying of other diseases.

For the study, researchers from the Carter Center in Atlanta compared villages where children received the antibiotic Zithromax to villages where treatment was delayed a year. The antibiotic cut the death rate in half, and the researchers speculate it helped prevent deaths from pneumonia, diarrhea, and malaria, the biggest killers of Ethiopian children.

The AP notes that trachoma is caused by bacteria that spreads to the eyes from fingers, clothing or, some researchers think, from flies. Over the years, blindness develops through repeated infections and scarring.

Read more »

Judge excludes testimony of expert witness in contact-lens solution lawsuits

Image via Wikipedia

US District Judge David C. Norton has thrown out testimony from an expert witness in a combined series of lawsuits against Bausch amp; Lomb, Inc. over ReNu with Moisture Loc, a contact-lens solution the company recalled three years ago because its use was linked to fusarium keratitis, a fungal eye infection that can lead to blindness.

In his Aug. 28 ruling, Norton refused the plaintiffs' bid to admit into evidence testimony by Elisabeth J. Cohen, MD, of the Jefferson Medical College and the Wills Eye Hospital. Norton said that Dr. Cohen's theory, in the way she presented it before the court, "is built on an unsupported hypothesis, and is thus fundamentally flawed and must be excluded."

The AP reports that Norton "said there's no reliable scientific basis for arguing that MoistureLoc caused another 1,024 lens wearers across the" US "to contract assorted bacterial, viral, and parasitic infections." The judge ruled that "attorneys relying on the expert opinion of" Dr. Cohen "did not submit any peer-reviewed studies, articles, or case reports concluding that there is a causal relationship between MoistureLoc and non-Fusarium infections."

Read more »

News my parents would never have imagined!

Scientists have produced monkeys with genetic material from two mothers, an advance that could help women with some inherited diseases have healthy children but that would raise a host of safety, legal, ethical and social questions if attempted in people

Researchers at Oregon Health amp; Science University developed a way to replace most of the genes in the eggs of one rhesus macaque monkey with genes from another monkey. They then fertilized the eggs with sperm, transferred the resulting embryos into animals' wombs and produced four apparently healthy offspring.

According to Bloomberg News, "defective mitochondria are passed only from mother to child, not from the father." Data indicate that nearly one in 4,000 births produce babies with defective mitochondria. At present, there is a technique that allows doctors to assess the egg cells of women with mitochondrial diseases and pick the healthiest ones to use with in vitro fertilization procedures. Still, some women do not have any "adequate egg cells," a fact that inspired the Oregon team to devise a way to "replace defective DNA in the mitochondria

Read more »

Fashion eyeglasses for children

Nebraska's Journal Star reported that eyeglasses are no longer the fashion don't for kids they once were, as wearers and manufacturers have realized they can be another accessory used to make a style statement.imatthews.com, Fashion eyeglasses for children, Aug 2009

You should read the whole article.

Read more »

Gene Therapy Creates a New Fovea

Gene therapy for an inherited form of blindness shows promise, a U.S. study shows.

According to a study published in the Aug. online edition of Human Gene Therapy and in a letter to the editor in the Aug. 13 issue of the New England Journal of Medicine, experimental gene therapy appeared to improve vision in three patients with Leber congenital amaurosis. In this condition an abnormal protein in sufferers' photoreceptors severely impairs their sensitivity to light. "It's like wearing several pairs of sunglasses in a dark room," says Artur Cideciyan, a researcher at the University of Pennsylvania in Philadelphia, who oversaw the trial

For the study, researchers from the University of Pennsylvania injected a gene encoding a functional copy of a light-sensitivity protein into a small part of one eye of three patients, all in their twenties and blind since birth. Three months after treatment, all three patients showed substantial improvements in their ability to detect light. Notably, one year after treatment, one patient discovered that she could read an illuminated clock in the family car for the first time in her life.

The authors suggested that the brain can adapt to new sensory capacity, even in people who have been blind since birth

Read more »

Alzheimer's Patients have difficulty perceiving certain kinds of visual contrast

Memory loss in Alzheimer's disease conceals dramatic changes to vision which may make people seem less mentally competent than they actually are.

Researchers are now testing whether they could improve the lives of people with Alzheimer's by helping them see better, using low-tech interventions such as colored dinner plates, oversize change purses, and special bingo cards. The scientists believe that small changes, such as making sure patients can see a light switch or the edge of a stair, could have important consequences for their independence and quality of life.

Researchers from Dr Alice Cronin-Golomb's lab at Boston University have discovered that Alzheimer's patients have difficulty picking up on certain kinds of visual contrast. Unfortunately, the vision loss does not show up on a typical eye exam. So the problem may be blamed on memory, when it really is eyesight. A new rule of thumb may be that if you want a person with Alzheimer's to be able to see something, use bold contrasting colors.

One of the BU group’s collaborators, Grover C. Gilmore, dean of the Mandel School of Applied Social Sciences at Case Western Reserve University, has found that healthy adults were able to identify letters faster than Alzheimer’s patients. Normally, such a delay might be chalked up to memory problems. But when he increased the visual contrast, he found that the difference between the two groups disappeared.

Read more »

The First Practice Academy

I just returned from a 2 day workshop called the The First Practice Academy.
This was a workshop held in Atlanta, GA. The sponsors were Ciba Vision and Essilor of America.
The entire event was aimed at a new business owner. I was one among over a 100 young doctors of optometry eager to listen to leaders in the industry. These leaders are individuals who started small themselves and grew into multi location, multi million dollar practices.
It was an amazing event - very inspiring and filled with great insights. I can't think of any other profession where this takes place. I have always been convinced that optometry is a very generous profession and this only went to further cement that opinion.
The speakers were Laurie L. Sorrenson, Amir Khoshnevis, Kelly Kerksick, Carole Burns, Mark Wright.

I want to thank the main sponsors for giving me an opportunity to be there...

Read more »

AARP says requiring road tests for seniors only is discriminatory

The CBS Evening News  reported that the number of Americans 65 and older expected to nearly double over the next 20 years and there are growing concerns about aging drivers behind the wheel. New Hampshire is one of only two states with mandatory road tests for seniors.
CBS correspondent Randall Pinkston explained, “In New Hampshire...every car and truck driver 75 or older must retake the road test to renew their driver's license”. Pinkston also pointed out that, while 15 percent of the nation's drivers are over 65, only 11 percent of them are involved in fatal crashes. But, starting at 65, their risk of accidents for every mile driven spikes up. By age 80, elderly drivers are as likely as 17-year-olds to have fatal crashes. Currently, Massachusetts is considering legislation to require older drivers to take road tests before renewing their licenses. Pinkston added, But, the American Association of Retired Persons, the AARP, says road tests only for older drivers are discriminatory, that health, not age is the decisive factor.

A similar bill is proposed in North carolina

Read more »

UIW School of Optometry to receive funding for San Antonio eye care clinic

University of the Incarnate Word (UIW) School of Optometry - (what a strange name for a school!) is in line to receive $250,000 from the government to help pay for a new eye-care clinic on San Antonio's East Side.

The school would use the money to provide eye exams and vision services to under-served residents in East San Antonio. The planned eye care clinic is slated to open in the spring of 2010. Funding for the project was included in the Labor, Health and Human Services, Education Appropriations bill, which recently passed the US House of Representatives, but still must still pass the US Senate

Read more »

Genetic Link To Age-related Cataracts Uncovered

Researchers from Case Western Reserve University have identified the EphA2 gene, which is associated with the formation of age-related cataract, a leading cause of blindness.



The gene encodes an enzyme that plays a role in the repair of damaged proteins in the eye. Expression of the EphA2 gene decreases with age, which means damaged proteins can clump together and cause the eye lens to become cloudy, resulting in obscured vision, according to the study in the July 31 issue of the journal PLoS Genetics

Read more »

BLOOD STEM CELLS PROGRAMED TO BECOME VISION CELLS

Florida researchers were able to program bone marrow stem cells to repair damaged retinas in mice, suggesting a potential treatment for one of the most common causes of vision loss in older people.

The success in repairing a damaged layer of retinal cells in mice implies that blood stem cells taken from bone marrow can be programmed to restore a variety of cells and tissues, including ones involved in cardiovascular disorders such as atherosclerosis and coronary artery disease.

In a paper slated to appear in the September issue of the journal Molecular Therapy, scientists describe how they used a virus carrying a gene that gently pushed cultured adult stem cells from mice toward a fate as retinal cells. Only after the stem cells were reintroduced into the mice did they completely transform into the desired type of vision cells, apparently taking environmental cues from the damaged retinas.

Read more »

Ozurdex Implant Approved for Macular Edema

Image via Wikipedia

An injectable eye implant approved by the U.S. Food and Drug Administration Thursday is the first product sanctioned to treat the eye disorder macular edema when it is caused by blockage of the retinal vein.

The Ozurdex eye implant treats macular edema by delivering a high concentration of the corticosteroid dexamethasone.

Macular edema occurs when the eye's macula -- a part of the retina -- swells because of fluid accumulation from leaking or blocked retinal veins. In a news release, device maker Allergan, Inc. said retinal vein occlusion is a significant cause of vision loss and the second most common disease of the retinal veins, behind diabetic retinopathy.

The implant, which is biodegradable, was evaluated in a pair of clinical studies involving about 1,300 people.

The treatment, to be injected in a physician's office, is expected to be available later this year

Read more »

ALLERGAN RECEIVES FDA APPROVAL FOR ACUVAIL

The FDA has approved Allergan Inc.'s Acuvail (ketorolac tromethamine ophthalmic solution) 0.45%, an advanced, preservative-free formulation of the NSAID ketorolac indicated for the treatment of pain and inflammation following cataract surgery. According to the company, Acuvail is formulated at pH 6.8, enabling deionized drug delivery on the corneal surface, and contains carboxymethylcellulose, which enables the drug to adhere to the ocular surface and enhances patient comfort. The company expects Acuvail to be available to physicians and patients in the United States in September 2009.

Read more »